Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A multi-time-point modality-agnostic patch-based method for lesion filling in multiple sclerosis.
The Role of Obstructive Sleep Apnea in Cognitive Dysfunction in Multiple Sclerosis.
Pediatric acquired CNS demyelinating syndromes: Features associated with multiple sclerosis.
Restoring immune tolerance in neuromyelitis optica: Part II.
Specific immune complexes augment in vitro acetylcholine receptor-specific T-cell proliferation.
Long-term efficacy and safety of intramuscular interferon beta-1a: Randomized postmarketing trial of two dosing regimens in Japanese patients with relapsing-remitting multiple sclerosis.
Severe tumefactive rebound of multiple sclerosis following fingolimod cessation.
Cognitive functions over the course of 1 year in multiple sclerosis patients treated with disease modifying therapies.
Herpes zoster laryngitis in a patient treated with fingolimod.
Exosomal proteome analysis of cerebrospinal fluid detects biosignatures of neuromyelitis optica and multiple sclerosis.
Transbulbar B-Mode Sonography in Multiple Sclerosis: Clinical and Biological Relevance.
Favorable outcome of a pregnancy after fampridine exposition during the first month.
Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial.
Treatment trials in progressive MS-current challenges and future directions.
A mouse model for testing remyelinating therapies.
Therapeutic efficacy of monthly subcutaneous injection of daclizumab in relapsing multiple sclerosis.
Short-term MRI measurements as predictors of EDSS progression in relapsing-remitting multiple sclerosis: grey matter atrophy but not lesions are predictive in a real-life setting.
Neuroprotection by central nervous system remyelination: Molecular, cellular, and functional considerations.
Major depressive disorder.
Reduced fecal GABA levels in multiple sclerosis patients.
Recovery from optic neuritis attack in neuromyelitis optica spectrum disorder and multiple sclerosis.
Evaluation of magnetic resonance imaging abnormalities in juvenile onset neuropsychiatric systemic lupus erythematosus.
Metabolic determinants of the immune modulatory function of neural stem cells.
Analysis of autoreactive CD4 T cells in experimental autoimmune encephalomyelitis after primary and secondary challenge using MHC class II tetramers.
An unusual infection in MS patient treated with dimethyl fumarate: A case report of omphalitis.
Pages
« first
‹ previous
…
750
751
752
753
754
755
756
757
758
…
next ›
last »